Furthermore, recent studies have linked the overexpression of m6A/m5C/m1A regulatory genes, including YBX1, to poor prognosis and distinct immune microenvironments in HCC and prostate cancer [171,172,173]. This evidence concerns the gene YBX1 and prostate carcinoma.